Xiao J,Wu CL,Gao YX,Wang SL,Wang L,Lu QY .2016 .Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China. Sci Rep, 6 : 38089.
Sarebanhassanabadi M,Mirhosseini SJ,Mirzaei M,Namayandeh SM,Soltani MH,Pedarzadeh A .2017 .The incidence of metabolic syndrome and the most powerful components as predictors of metabolic syndrome in Central Iran: a 10-year follow-up in a cohort study. Iranian Red Crescent Med, 19(7) : e14934.
Neto L,Garcia JC,Xavier MDA,Borges JWP,Araújo MFMD,Damasceno MM .2017 .Prevalence of metabolic syndrome in individuals with type 2 diabetes mellitus. Rev Bras Enferm, 70(2) : 265-70.
Kim CJ,Park J,Kang SW J .2015 .Prevalence of metabolic syndrome and cardiovascular risk level in a vulnerable population. Int J Nurs Pract, 21(2) : 175-83.
Shahrokh S,Heydarian P,Ahmadi F .2012 .Association of inflammatory biomarkers with metabolic syndrome in hemodialysis patients. Ren Fail, 34(9) : 1109-13.
Gomes AR,de Sousa AW .2016 .Nonalcoholic Fatty Liver Disease in Metabolic Syndrome, Epidemiology and Pathogenesis. SmGroup, : 1-15.
Dragsbaek K,Neergaard JS,Laursen JM,Hansen HB,Christiansen C,Beck-Nielsen H .2016 .Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: challenging the current definition. Medicine, 95(36) : e4806.
Yang KC,Hung HF,Lu CW,Chang HH,Lee LT,KC. LT .2016 .Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci Rep, 6 : 27034.
Daudt LD,Musskopf ML,Mendez M,Remonti LLR,Leitão CB,Gross JL .2018 .Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res, 32 : e35.
Alizadeh S,Ahmadi M,Ghorbani Nejad B,Djazayeri A,ShabBidar S A .2018 .Metabolic syndrome and its components are associated with increased chronic kidney disease risk: Evidence from a metaanalysis on 11 109 003 participants from 66 studies. Int J Clin Pract, 72 : e13201.
Alfa-Wali M,Boniface S,Sharma A,Tekkis P,Hackshaw A,Antoniou A .2015 .Metabolic syndrome (MetS) and risk of colorectal cancer (CRC): a systematic review and meta-analysis. World J Surg Med, 4(7) : 41-52.
Kamkar MZ,Sanagoo A,Zargarani F,Jouybari L,Marjani A .2016 .Metabolic syndrome in patients with severe mental illness in Gorgan. J Nat Sc Biol Med, 7(1) : 62-7.
Lee SH,Choi H,Cho BL,An AR,Seo YG,Jin HS .2016 .Relationship between metabolic syndrome and rheumatoid arthritis. Korean J Fam Med, 37(1) : 44-50.
Kaykhaei MA,Adineh HA,Mohammadi M,Dabiri S,Ansari-Moghaddam A .2019 .Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies. Diabetes Metab Syndr, 13(1) : 792-99.
Mohagheghi A,Panahi A,Hedayat DK .2011 .The effects of metabolic syndrome on left main coronary artery stenosis in coronary angiograms of patients: a two year study. TUMS, 69(9) : 571-75.
Hadaegh F,Zabetian A,Tohidi M .2008 .Relationship between metabolic syndrome and coronary heart disease in Iranian population the Tehran lipid and glucose study. Tehran Univ Med J, 66(8) : 590-98.
Assali A,Ghayour-Mobarhan M,Sahebkar A,Hassani M,Kasaian J,Tatari F .2011 .Association of angiotensin II type 1 receptor gene A1166C polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease. Eur J Intern Med, 22(3) : 254-61.
Ghanei Gheshlagh R,Nourozi Tabrizi K,Shabani F,Zahednezhad H .2016 .Association between metabolic syndrome and sleep apnea in elderly patients with cardiovascular diseases. Med Sci J Islamic Azad Univ Tehran Med Branch, 26(1) : 46-51.
Ardeshiri M,Faritus Z,Ojaghi-Haghighi Z,Bakhshandeh H,Kargar F,Aghili R .2014 .Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery. Res Cardiovasc Med, 3(3) : e20270.
Anvari MS,Boroumand MA,Pourgholi L,Sheikhfathollahi M,Rouhzendeh M,Rabbani S .2009 .Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res, 40(5) : 399-405.
Sadeghian S,Darvish S,Salimi S,Esfehani FA,Fallah N,Mahmoodian M .2007 .Metabolic syndrome: stronger association with coronary artery disease in young men in comparison with higher prevalence in young women. Coron Artery Dis, 18(3) : 163-8.
Mahdavi Anari L,Ghanbari-Firoozabadi M,Ansari Z,Emami M,Vafaii Nasab M,Nemaiande M .2015 .Effect of Cardiac Rehabilitation Program on Heart Rate Recovery in Coronary Heart Disease. J Teh Univ Heart Ctr, 10(4) : 176-81.
Harandi SA,Sarrafzadegan N,Sadeghi M,Talaei M,Dianatkhah M,Oveisgharan S .2016 .Do cardiometabolic risk factors relative risks differ for the occurrence of ischemic heart disease and stroke?. ResCardiovasc Med, 5(1) : e30619.
Kabir A,Sarrafzadegan N,Amini A,Aryan RS,Kerahroodi FH,Rabiei K .2012 .Impact of cardiac rehabilitation on metabolic syndrome in Iranian patients with coronary heart disease: the role of obesity. Rehabil Nurs, 37(2) : 66-73.
Parizadeh SA,Jamialahmadi K,Rooki H,Zaim-Kohan H,Mirhafez SR,Hosseini N .2015 .Association of neuropeptide Y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease. Ann Hum Biol, 42(2) : 179-83.
Dehghani MR,Rezaei Y,Fakour S,Arjmand N. .2016 .White blood cell count to mean platelet volume ratio is a prognostic factor in patients with non-ST elevation acute coronary syndrome with or without metabolic syndrome. Korean Circ J, 46(2) : 229-38.
Sarrafzadegann N,Ashrafi F,Noorbakhsh M,Haghighi M,Sadeghi M,Mazaheri F .2009 .Association of breast artery calcification with coronary artery disease and carotid intima-media thickness in premenopausal women. East Mediterr Health J, 15(6) : 1474-82.
Sadr Bafghi S M M,Namayande S M A,Soltani MH,Motefaker M .2005 .Examination of premature myocardial infarction in Yazd. TUMJ, 7 : 579-89.
Saeidi M. Metabolic .2009 .Syndrome and Hypertension in Diabetic Patients. IJEM, 11(1) : 11-16.
Nakhjavani N,Imani M,Larry M,Aghajani-Nargesi A,Morteza A,Esteghamati A .2014 .Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status. J Diabetes Metab Disord, 13(1) : 102.
Marjani A,Shirafkan A .2011 .The metabolic syndrome in type 2 diabetic patients in Gorgan: According to NCEP ATPIII and IDF definitions. Diabetes Metab Syndr, 5(4) : 207-10.
Rashidi H,Fardad F,Ghaderian B,Shahbazian HB,Latifi M,Karandish M .2012 .Prevalence ofMetabolic Syndrome and its Predicting Factors in Type 2 Diabetic Patients in Ahvaz. Jundishapur Sci Med J, 11(1) : 163-75.
Foroozanfar Z,Najafipour H,Khanjani N,Bahrampour A,Ebrahimi H . .2015 .The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran. Iran J Med Sci, 40(6) : 522-25.
Ziaee A,Hashemipoor S,Karimzadeh T,Jalalpoor A,Javadi A .2012 .Relation of Vitamin D3 Level with metabolic Syndrome Indices among Patients with Diabetes and Non-Diabetic Individuals. J Ardabil Univ Med Sci, 12(2) : 149-56.
Derakhshan R,Khoshnood A,Balaee P .2010 .Evaluation of Abdominal Obesity Prevalence in Diabetic Patients and Relation with Other Factors of Metabolic Syndrome. IJEM, 12(3) : 208-12.
Hosseinpanah F,Rambod M,Sadeghi L,Foroutan M,Naseri M .2006 .Assessing predicting factors in non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes. , 30(1) : 9-15.
Nargesi AA,Esteghamati S,Heidari B,Hafezi-Nejad N,Sheikhbahaei S,Pajouhi A .2016 .Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension. J Hypertens, 34(5) : 974-80.
Sharifi F,Jaberi Y,Mirzamohammadi F,Mirzamohammadi H,Mousavinasab N. .2013 .Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose. Indian J Endocrinol Metab, 17(5) : 899-905.
Gholamzadeh Baeis M,Mohebi S,Miladinia M,Parham M. .2016 .Study of Metabolic Syndrome Based on the NCEP/ATP III Criteria in People at Risk for Diabetes. Qom Univ Med Sci J, 10(6) : 42-50.
Veissi M,Anari R,Amani R,Shahbazian H,Latifi SM .2016 .Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran. Diabetes Metab Syndr, 10(2 Suppl 1) : S26-29.
Vafaeimanesh J,Bagherzadeh M,Mirzaei A,Parham M,Norouzinia M,Vafaee R .2016 .Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients. Gastroenterol Hepatol Bed Bench, 9(Suppl1) : S36-S41.
Nakhjavani M,Esteghamati A,Tarafdari AM,Nikzamir A,Ashraf H,Abbasi M. .2011 .Association of plasma leptin levels and insulin resistance in diabetic women: a cross-sectional analysis in an Iranian population with different results in men and women. Gynecol Endocrinol, 27(1) : 14-9.
Janghorbani M,Amini M. .2016 .Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study. , 68(1) : 19-25.
Sobhani N,Entezari MH,Feizi A,Asgari GH,Reiesi J .2016 .Association of Dietary Fatty Acids with Metabolic Syndrome Indices in Patients with Type 2 Diabetes. J Isfahan Med Sch, 34(383) : 563-71.
Bonakdaran SH,Gharebaghi M,Vahedian M. .2009 .Prevalance of Anemia in Type 2 Diabetic Patients and the Role of Nephropathy. Iranian Journal of Endocrinology & Metabolism, 11(2) : 127-34.
Jahed A,Hosseinpanah F .2007 .Prevalence and predictive factors of lada “latent autoimmune diabetes in adults” in newly diagnosed diabetics of tehran lipid and glucose study. Ijdld, 7(1) : 43-54.
Pourteymour Fard Tabrizi F,Alipoor B,Sadaghiani MM,Ostadrahimi A,Malek Mahdavi A .2013 .Metabolic syndrome and its characteristics among reproductive-aged women with polycystic ovary syndrome: A cross-sectional study in northwest Iran. Int J Fertil Steril, 6(4) : 244-49.
Moini A,Javanmard F,Eslami B,Aletaha N. .2012 .Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of Tehran. Iran J Reprod Med, 10(2) : 127-30.
Shahbazian HB,Shahbazian N,Haghighi M,Khodadadi M. .2012 .Prevalence of Metabolic Syndrome in Patients with Poly Cystic Ovarian Syndrome in Ahvaz. Sci Med J, 10(6) : 595-604.
Mehrabian F,Khani B,Kelishadi R,Kermani N. .2011 .The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females. J Res Med Sci, 16(6) : 763-69.
Madani T,Hosseini R,Ramezanali F,Khalili G,Jahangiri N,Ahmadi J .2016 .Metabolic syndrome in infertile women with polycystic ovarian syndrome. Arch Endocrinol Metab, 60(3) : 199-204.
Zahiri Z,Sharami SH,Milani F,Mohammadi F,Kazemnejad E,Ebrahimi H .2016 .Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril, 9(4) : 490-96.
Layegh P,Mousavi Z,Tehrani DF,Parizadeh SM,Khajedaluee M. .2016 .Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and nonobese PCOS patients. Int J Reprod Biomed (Yazd), 14(4) : 263-70.
Ebrahimi-Mamaghani M,Saghafi-Asl M,Pirouzpanah S,Aliasgharzadeh A,Aliashrafi S,Rezayi N .2015 .Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr, 33(1) : 157-67.
Moradi S,Darvishi N. .2009 .Evaluation of the Prevalence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome Referred to the Institute of Endocrine and Metabolism. RJMS, 16(63) : 132-37.
Forootan M,Tabatabaeefar M,Yahyaei M,Maghsoodi N. .2012 .Metabolic syndrome and colorectal cancer: a cross-sectional survey. Asian Pacific J Cancer Prev, 13(10) : 4999-5002.
Saadatian V,Ghareh S,Shakeri MT,Emadzadeh M,Taraz Jamshidi SH,Emadzadeh A .2012 .The Frequency of Metabolic Syndrome among Female Patients Admitted in Psychiatry Ward. Medical Journal of Mashhad University of Medical Sciences, 54(4) : 230-37.
Rezaei O,Khodaie-Ardakani MR,Mandegar MH,Dogmehchi E,Goodarzynejad H .2009 .Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia. Int J Psychiatry Med, 39(4) : 451-62.
Khalili F .2015 .Metabolic syndrome in schizophrenic patients: prevalence and findings in Bandar Abbas. Intl Res J.Appl BasicSci, 9(11) : 1890-94.
Shakeri J,Karimi K,Farnia V,Golshani S,Alikhani M. .2016 .Prevalence of metabolic syndrome in patients with schizophrenia referred to farabi hospital, Kermanshah, Iran. Oman Med, 31(4) : 270-75.
Moayedi F,Abdolrasouli LH,Fardan Y,Hosseini S,Sadeghi P .2015 .Prevalence of metabolic syndrome among bipolar patients. RJ PBCS, 6(2) : 910-14.
Goughari AS,Mazhari S,Pourrahimi AM,Sadeghi MM,Nakhaee N. .2015 .Associations between components of metabolic syndrome and cognition in patients with schizophreni. J Psychiatr Pract, 21(3) : 190-97.
Ghoreishi A,Shajari Z,Sharifi F,Ghoreishi AB .2016 .Metabolic Syndrome, 10year-Coronary Heart Disease and 8year-Diabetes Mellitus Prediction in the Patients with Schizophrenia. Adv Biores, 7(4) : 155-62.
Ghanei Geshlagh R,Hemmati Maslakpak M,Ghoci S M .2011 .Sleep apnea and metabolic syndrome in hemodialysis patients. Urmia Medical Journal, 22(4) : 339-45.
Marjani A,Moujerloo M,Hezarkhani S M .2013 .Age related metabolic syndrome among hemodialysis patients in Gorgan, Iran. , 7 : 15-8.
Mortazavi M,Seirafian S,Naini AE,Zamani N,Moien N. .2012 .The Prevalence of Metabolic Syndrome in Patients on Hemodialysis and Peritoneal Dialysis: A Comparative Study. JIMS, 29 : 171.
Razeghi E,Heydarian P,Heydari M. .2011 .The frequency of prediabetes and contributing factors in patients with chronic kidney disease. Rev Diabet Stud, 8(2) : 276-81.
Maleki A,Montazeri M,Rashidi N,Montazeri M .2015 .Metabolic syndrome and its components associated with chronic kidney disease. Journal of research in medical sciences: the official. J Res Med Sci, 20(5) : 465-69.
Edalat-Nejad M,Zameni F,Qlich-Khani M .2015 .Geriatric nutritional risk index: a mortality predictor in hemodialysis patients. Saudi J Kidney Dis Transpl, 26(2) : 302-8.
Fattahi MR,Niknam R,Safarpour A,Sepehrimanesh M,Lotfi M. .2016 .The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study. Middle East J Dig Dis, 8(2) : 131-37.
Safavi F,Yousefzadeh GH,Shokoohi M,Safavi S,Najafipour H,Shadkam Farokhi M. H .2015 .Prevalence of metabolic syndrome in patients with periodontal disease. JKMU, 22(3) : 229-39.
Hossein Tehrani M,Karimi M,Kalhor L,Mazloumzade S. .2015 .Prevalence of Metabolic Syndrome and its Components in Patients with Osteoarthritis. J Adv Med Biomed Res, 23(96) : 68-77.
Goshayeshi L,Saber H,Sahebari M,Rezaieyazdi Z,Rafatpanah H,Esmaily H .2012 .Association between metabolic syndrome, BMI, and serum vitamin D concentrations in rheumatoid arthritis. Clin Rheumatol, 31(8) : 1197-203.
Shirani F,Khaleghi S,Nikfam M,Pourmojarab A .2016 .The prevalence of metabolic syndrome in psoriatic arthritis patients, a hospitalbased cross-sectional study on Iranian population. TUMJ, 74(8) : 569-77.
Ford ES,Schulze MB,Pischon T,Bergmann MM,Joost HG,Boeing H .2008 .Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and NutritionPotsdam Study. Cardiovasc diabetol, 7(1) : 35.
Cheung BM,Wat NM,Man YB,Tam S,Thomas GN,Leung GM .2007 .Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes care, 30(6) : 1430-36.
Lorenzo C,Okoloise M,Williams K,Stern MP,Haffner SM .2003 .The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes care, 26(11) : 3153-59.
Mottillo S,Filion KB,Genest J,Joseph L,Pilote L,Poirier P .2010 .The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol, 56(14) : 1113-32.
Salman Roughani H,Mohammadi S M L,Salman Roughani R .2008 .ZaremehrjerdiA. Investigating the Indices of Insulin Resistance and Metabolic Syndrome in Patients with Asymptomatic Fatty Liver. Govaresh, 13(2) : 75-79.
Ghamar-Chehreh ME,Amini M,Khedmat H,Moayed Alavian S,Daraei F,Mohtashami R .2012 .Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver diseaseAsian. Pac J Trop Biomed, 2(9) : 702-6.
Noori N,Hosseinpanah F,Nasiri AA,Azizi F .2009 .Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr, 19(3) : 228-37.
Cho JA,Lee SJ,Reid EA,Jee SH .2013 .Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study. Maturitas, 75(1) : 74-80.
Raikou V,Gavriil S. .2018 .Metabolic syndrome and chronic renal disease. Diseases, 6(1) : 12.
Naik M,Bhat T,Jalalie U,Ganayie M T,Waseem M,Bhat A .2017 .Prevalence and predictors of metabolic syndrome in rheumatoid arthritis. Int J Res Med Sci, 5(8) : 3322-28.
Lee SG,Kim JM,Lee SH,Kim KH,Kim JH,Yi JW .2013 .Is the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?. Korean J Intern Med, 28(2) : 206-15.
Jinjuvadia R,Lohia P,Jinjuvadia C,Montoya S,Liangpunsakul S. .2013 .The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol, 47(1) : 33-44.
Lim HS,Shin EJ,Yeom JW,Park YH,Kim SK .2017 .Association between nutrient intake and metabolic syndrome in patients with colorectal cancer. Clin Nutr Res, 6(1) : 38-46.
Nibali L,Tatarakis N,Needleman I,Tu YK,D'Aiuto F,Rizzo M .2013 .Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab, 98(3) : 913-20.
Kaye EK,Chen N,Cabral HJ,Vokonas P,Garcia RI .2016 .Metabolic syndrome and periodontal disease progression in men. J Dent Res, 95(7) : 822-28.
Hallajzadeh J,Khoramdad M,Karamzad N,Almasi-Hashiani A,Janati A,Ayubi E .2018 .Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res, 10(2) : 56-69.
Vancampfort D,Vansteelandt K,De Herdt A,Sienaert P .2013 .Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry, 170(3) : 265-74.